2018
DOI: 10.1139/cjpp-2017-0023
|View full text |Cite
|
Sign up to set email alerts
|

Sodium tanshinone IIA sulfonate prevents lipopolysaccharide-induced inflammation via suppressing nuclear factor-κB signaling pathway in human umbilical vein endothelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 39 publications
1
18
0
Order By: Relevance
“…Tan IIA has been reported to have diverse pharmacological effects, including anti-inflammation, anti-apoptosis, and regulation of the immune response (28). Previous studies have indicated that Tan IIA may inhibit the LPS-induced expression of inflammation-associated cytokines in various cell types (19,29,30). In the present study, LPS significantly increased the expression of MCP-1, IL-6, and TNF-α in VSMCs, which is consistent with a previous study (4).…”
Section: Discussionsupporting
confidence: 92%
“…Tan IIA has been reported to have diverse pharmacological effects, including anti-inflammation, anti-apoptosis, and regulation of the immune response (28). Previous studies have indicated that Tan IIA may inhibit the LPS-induced expression of inflammation-associated cytokines in various cell types (19,29,30). In the present study, LPS significantly increased the expression of MCP-1, IL-6, and TNF-α in VSMCs, which is consistent with a previous study (4).…”
Section: Discussionsupporting
confidence: 92%
“…Bi et al [48] designed and tested the endothelial protective effects of tanshinone IIa derivatives and found that several derivatives have increased efficacy against H 2 O 2 -induced injury via Nrf2 (nuclear factor (erythroid-derived 2)-like-2 factor) activation and superior water solubility. (2) Preventing inflammatory responses in endothelial cells and endothelial progenitor cells and preventing monocyte adhesion to diseased endothelium: Tanshinone IIa has potent anti-inflammatory effects by blocking the upregulation of pro-inflammatory mediators, such as tumor necrosis factor α (TNF-α), intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), monocyte chemotactic protein 1 (MCP-1), E-selectin, and interleukins (IL-8 & IL-1β), in response to proinflammatory stimuli [50][51][52][53][54][55][56] , thus reducing monocyte adhesion to endothelial cells [50,54,56] . (3) Regulation of vascular tone and vasorelaxation by increasing NO and decreasing endo- thelin-1 (ET-1): Several reports have revealed that tanshinone IIa increases the production of NO [57][58][59] under different stress conditions in endothelial cells by increasing eNOS levels [58,60,61] and eNOS phosphorylation at ser1177 [61] while blocking eNOS ser1177 dephosphorylation [61] .…”
Section: Protective Effects Of Tanshinone Iia On Endothelial Functionmentioning
confidence: 99%
“…The present experimental study illustrated that the reduced apoptotic levels were detected in tumorbearing mice exposed to the IH environment. The apoptotic levels can be improved by TSA under the IH condition in which NF-kB signaling pathway may be partly involved [35,36].…”
Section: Effect Of Tsa On Nrf2 and Nf-kb Expressionmentioning
confidence: 99%